
Randi Hernandez
Randi Hernandez was science editor at BioPharm International from September 2014 to May 2017.
Articles by Randi Hernandez





February 15, 2016.

January 05, 2016.

October 28, 2015.

August 28, 2015.

August 27, 2015.


New cell-culture techniques, biomanufacturing formats, and the expansion of single-use applications are driving rapid change in the biopharma market.

Prescription drug usage data on more than one million Marketplace enrollees suggest that costs for specialty drugs were 36% higher for people with Obamacare.

The House Energy and Commerce Committee gave unanimous approval to the landmark 21st Century Cures Act reform bill on May 21, 2015.

The grants will be offered to investigators conducting research in the field of PCSK9 biology.

Novartis will make payments to Juno to settle a patent dispute covering chimeric antigen receptor T-cell (CAR-T) therapies.

23 February, 2015.

Pfizer announced on Feb. 5, 2015 that it is acquiring injectable, infusible, and biosimilar manufacturer Hospira for nearly $17 billion after the assumption of debt.

GlaxoSmithKline (GSK) announced on January 26 that it will freeze vaccine prices for Gavi-eligible countries for up to 10 years after the country graduates from Gavi support.

CVS confirmed this week that it will exclusively offer Gilead's Harvoni and Sovaldi to members through its CVS/Caremark commercial, exchange, Medicare Part D, and Medicaid formularies.

The Pharmaceutical Care Management Association (PCMA), an organization that represents the nation’s leading pharmacy benefit managers (PBMs), which administer prescription drug plans for over 210 million Americans, released a new white paper investigating FDA’s influence on drug prices and competition in the pharmaceutical marketplace.

After a change in distribution strategy at Genentech, Ascension Health has prohibited sales representatives from the drug maker to solicit physicians at Ascension’s 1900 sites of care around the country.

Researchers at the Massachusetts Institute of Technology (MIT) have devised a novel drug capsule coated with tiny needles to deliver large-molecule biopharmaceuticals.
Latest Updated Articles
FDA "Stymies Competition in Drug Industry", Says PCMAPublished: November 19th 2014 | Updated:
Healthcare Nonprofit Bans Genentech RepsPublished: October 8th 2014 | Updated:
Jagged Little Pill Drugs Through a MicroneedlePublished: October 6th 2014 | Updated:
Gilead and CVS Health in Drug Exclusivity DealPublished: January 8th 2015 | Updated:
GSK Freezes Prices for Vaccine Alliance MembersPublished: January 28th 2015 | Updated:
Pfizer to Acquire Hospira for Nearly $17 BillionPublished: February 9th 2015 | Updated:
